why choose us

First received: June 20, 2025

Clinical Trial: Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Schizophenia Disorder
Schizoaffective Disorder
Bipolar Disorder
Psychiatric Disorders

Study Type: INTERVENTIONAL


Official Title: Reduction of Anticholinergic Medications Project (RAMP) Among Persons With Schizophrenia or Other Psychiatric Disorders Across UPMC Behavioral Healthcare Partner Organizations Using a Stepped-wedge, R

Brief Summary: The goal of this study is to reduce Anticholinergic Medication (ACM) in persons with psychoses or serious mental illness, when these medications are no longer needed.

Read more